Stay updated with breaking news from Laurus Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read more about Laurus Labs rallies 5% on credit rating upgrade; stock hits record high on Business Standard. The company is looking to build new capacities/facilities that would propel its growth in the coming years
Shares of Laurus Labs moved higher by 5 per cent to Rs 474.95 on the BSE in intra-day trade on Monday, erasing a 4.5 per cent fall witnessed in the past two trading days, on a strong growth outlook. The stock of the pharmaceutical company hit a record high of Rs 482.65 on April 29, the day on which the company announced its January-March quarter (Q4FY21) earnings. The company’s Q4 revenues grew 68.3 per cent year-on-year (YoY) to Rs 1,412 crore with strong growth across segments. Earnings before interest, taxes, depreciation and amortization (Ebitda) margins improved 1,059 basis points (b...
Laurus Labs net surges on higher sales Updated: Updated: Share Article AAA Drugmaker Laurus Labs has reported a consolidated net profit of ₹297 crore for the quarter ended March on the back of good show in key business segments. The drugmaker had posted a net profit of ₹110.15 crore in the same period last fiscal. Revenue from operations increased to ₹1,412 crore (₹839.14 crore). For the full fiscal, net profit stood at ₹984 crore (₹255.27 crore), while revenue from operations was ₹4,814 crore (₹2,831.72 crore). The company has declared an interim dividend of 80 paise (40%) p...
The drug maker's consolidated net profit soared 170% to Rs 297 crore on 68% surge in net sales to Rs 1,412 crore in Q4 FY21 over Q4 FY20. On a consolidated basis, EBITDA grew 147% to Rs 477 crore in Q4 FY21 over Q4 FY20 while EBITDA margins stood at 34%. The board approved an interim dividend amounting to Re 0.80 per share. The net profit soared 286% to Rs 984 crore on 70% surge in net sales to Rs 4,814 crore in the year ended March 2021 (FY21) over the year ended March 2020 (FY20). EBITDA grew 176% to Rs 1,573 crore in FY21 over FY20 while EBITDA margins stood at 33%. The Reaseach and Deve...
Laurus Labs’ Q4 net at ₹297 crore April 29, 2021 Its total revenue increased 68% at ₹1,412 crore Laurus Labs Ltd’s consolidated net profit more than doubled at ₹297 crore in the fourth quarter ended March 31, 2021 compared to ₹110 crore in the corresponding quarter of the previous fiscal. The total revenue increased 68 per cent at ₹1,412 crore. For the full year, the net profit increased 286 per cent to ₹984 crore on a revenue of ₹4,814 crore which registered 68 per cent increase over previous financial year. “We delivered a strong performance in all divisions, and we a...